Quantitative imaging assessment of blood-brain barrier permeability in humans

Yoash Chassidim, Ronel Veksler, Svetlana Lublinsky, Gaby S Pell, Alon Friedman, Ilan Shelef, Yoash Chassidim, Ronel Veksler, Svetlana Lublinsky, Gaby S Pell, Alon Friedman, Ilan Shelef

Abstract

The blood-brain barrier (BBB) is a functional and structural barrier separating the intravascular and neuropil compartments of the brain. It characterizes the vascular bed and is essential for normal brain functions. Dysfunction in the BBB properties have been described in most common neurological disorders, such as stroke, traumatic injuries, intracerebral hemorrhage, tumors, epilepsy and neurodegenerative disorders. It is now obvious that the BBB plays an important role in normal brain activity, stressing the need for applicable imaging and assessment methods. Recent advancements in imaging techniques now make it possible to establish sensitive and quantitative methods for the assessment of BBB permeability. However, most of the existing techniques require complicated and demanding dynamic scanning protocols that are impractical and cannot be fulfilled in some cases. We review existing methods for the evaluation of BBB permeability, focusing on quantitative magnetic resonance-based approaches and discuss their drawbacks and limitations. In light of those limitations we propose two new approaches for BBB assessment with less demanding imaging sequences: the "post-pre" and the "linear dynamic" methods, both allow semi-quantitative permeability assessment and localization of dysfunctional BBB with simple/partial dynamic imaging protocols and easy-to-apply analysis algorithms. We present preliminary results and show an example which compares these new methods with the existing standard assessment method. We strongly believe that the establishment of such "easy to use" and reliable imaging methods is essential before BBB assessment can become a routine clinical tool. Large clinical trials are awaited to fully understand the significance of BBB permeability as a biomarker and target for treatment in neurological disorders.

Figures

Figure 1
Figure 1
Pre-post comparison method. The enhancement-distribution histograms of three representing regions (ROIs): eyeball, muscle and a blood vessel. Black line represents an enhancement distribution in the muscle ROI (temporal muscle), green line for eyeball ROI (vitreous humor) and red line demonstrates blood ROI (superior sagittal sinus). Author:
Figure 2
Figure 2
Semi-quantitative assessment for pre-post comparison method. (A) Enhancement distribution at range of 20%-100% defined with muscle ROI. (B) Brain masking: CSF – blue, grey matter – red, white matter – green. (C) Permeable pixels at region defined by total brain region mask. (D) Permeable pixels at region defined by brain tissue mask, excluding pixels relating to ventricles and subarachnoid space appearing in C. (E) Clustering procedure applied to D. Single pixels and regions smaller than minimal size of 10 pixels were removed.
Figure 3
Figure 3
The linear dynamic method. A comparison of normalization methods and effect on the estimated parameters. The slope and intercept are displayed on an arbitrary scale (different scale for each method), whereas the R2 is always scaled in the range of 0–1. The parameters maps are smoothed using a median filter with a kernel of 3x3 voxels for display purpose.
Figure 4
Figure 4
Signal intensity changes in different tissues. Intensity is relative to the intensity in the first scan.
Figure 5
Figure 5
A comparison of the permeability constant Ktrtans,( min-1) from Toft’s model (A), the normalized slope (sec-1) from the linear model (B) and the difference percentage from the post-pre method (C). Quantitative comparison between the 3 methods is not trivial, so a qualitative comparison is shown. False color scales reflect Ktrtans (A), normalized slope (B) and percent difference (C).

References

    1. Shlosberg D, Benifla M, Kaufer D, Friedman A. Blood–brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol. 2010;6:393–403. doi: 10.1038/nrneurol.2010.74.
    1. Abbot NJ, Friedman A. Overview and introduction: The blood–brain barrier in health and disease. Epilepsia. 2012;53(Suppl. 6):1–6.
    1. Tomkins O, Shelef I, Kaizerman I, Eliushin A, Afawi Z, Misk A, Gidon M, Cohen A, Zumsteg D, Friedman A. Blood–brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiat. 2008;79:774–777. doi: 10.1136/jnnp.2007.126425.
    1. Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A, Shelef I. Blood–brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychiatry Neurol. 2011;765923:1–11.
    1. Schoknecht K, Shalev H. Blood–brain barrier dysfunction in brain diseases: Clinical experience. Epilepsia. 2012;53(Suppl. 6):7–13.
    1. Rebeles F, Fink J, Anzai Y, Maravilla KR. Blood–brain barrier imaging and therapeutic potentials. Top Magn Reson Imaging. 2006;17:107–116. doi: 10.1097/RMR.0b013e31802f5df9.
    1. Nagaraja TN, Knight RA, Ewing JR, Karki K, Nagesh V, Fenstermacher JD. In: The blood–brain and other neural barriers. Sukriti N, editor. New York: Humana Press; 2011. Multiparametric Magnetic Resonance Imaging and Repeated Measurements of Blood–brain Barrier Permeability to Contrast Agents; pp. 193–212.
    1. Schellenberg AE, Buist R, Yong VW, Del Bigio MR, Peeling J. Magnetic resonance imaging of blood-spinal cord barrier disruption in mice with experimental autoimmune encephalomyelitis. J Magn Reson Med. 2007;58:298–305. doi: 10.1002/mrm.21289.
    1. Knight RA, Nagaraja TN, Ewing JR, Nagesh V, Whitton PA, Bershad E, Fagan SC, Fenstermacher JD. Quantitation and localization of blood-to-brain influx by magnetic resonance imaging and quantitative autoradiography in a model of transient focal ischemia. J Magn Reson Med. 2005;54:813–821. doi: 10.1002/mrm.20629.
    1. Sourbron SP, Buckley DL. Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability. Phys Med Biol. 2012;57:R1–R33. doi: 10.1088/0031-9155/57/2/R1.
    1. Benjamini Y. Discovering the false discovery rate. Journal of the Royal Statistical Society Series B. 2010;72:405–416. doi: 10.1111/j.1467-9868.2010.00746.x.
    1. Jelescu IO, Leppert IR, Narayanan S, Araújo D, Arnold DL, Pike GB. Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood–brain barrier permeability measurement in enhancing multiple sclerosis lesions. J Magn Reson Imaging. 2011;33:1291–1300. doi: 10.1002/jmri.22565.
    1. Brix G, Kiessling F, Lucht R, Darai S, Wasser K, Delorme S, Griebel J. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. J Magn Reson Med. 2004;52:420–429. doi: 10.1002/mrm.20161.
    1. Tofts PS, Kermode AG. Measurement of the blood–brain barrier permeability and leakage space using dynamic MR imaging-Fundamental concepts. J Magn Reson Med. 1991;17:357–367. doi: 10.1002/mrm.1910170208.
    1. Tofts PS, Brix G, Buckley DL. et al.Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–232. doi: 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>;2-S.
    1. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7:91–101. doi: 10.1002/jmri.1880070113.
    1. Sourbron S. Technical aspects of MR perfusion. Eur J Radiol. 2010;76:304–313. doi: 10.1016/j.ejrad.2010.02.017.
    1. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. J Magn Reson Med. 2006;56:993–1000. doi: 10.1002/mrm.21066.

Source: PubMed

3
Abonnieren